Building Trust to Ensure Diversity, Equity, Inclusion in Clinical Research

Community engagement is a massive challenge when it comes to diversity, equity and inclusion. This session will evaluate what has not worked and focus on the learnings so pharma/biotech can more successfully engage with under-represented communities long term. Key topics include: 

• How can pharma have more of a presence in the community and what does that mean to patients?
• What are the best ways to build trust and gain community insights from patients where studies are implemented?
• What will lead patients to embrace it and utilize it and make this whole effort more sustainable?
• What does community engagement look like for different stakeholders (patients, advocacy, pharma)?
• What are those institutions that might already be there that can be built upon?
• How have community centers of excellence been able to recruit racial, ethnic minority populations to successfully get input into studies?

Moderated by:

Adrelia Allen, PharmD, Director, Clinical Trial Patient Diversity, Global Clinical Trial Operations, Merck Research Labs

Panelists:

• Tesheia Johnson, MBA, Deputy Director and Chief Operating Office, YCCI and Director, Clinical Research, Yale School of Medicine
• Karen Peterson, Patient Advocate, Karen's Club
• Ebony Scott, Director, Lupus Therapeutics, an affiliate of Lupus Research Alliance
• Ash Rishi, CEO, COUCH Health
• Angela Rochelle, Account Director, Head, Diversity Initiatives in Clinical Trials, Langland

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org